What’s Going On With Monopar Therapeutics Shares Friday?
Monopar entered into an agreement with Alexion, AstraZeneca Rare Disease for an exclusive worldwide license to ALXN-1840 for Wilson disease. read more
Monopar entered into an agreement with Alexion, AstraZeneca Rare Disease for an exclusive worldwide license to ALXN-1840 for Wilson disease. read more
Capri Holdings’ acquisition by Tapestry has been blocked by a judge, leading to a drop in CPRI shares and an appeal by both companies. read more
Newell Brands reports Q3 earnings in line with estimates, boosts FY24 EPS guidance, and sees shares jump. read more
FullMoon Sesh debuts in Argentina, bringing global cannabis culture to Buenos Aires with elite judges, live performances, and more. read more
Cultivators and brands want to introduce more nuanced or tailored THC products into the market. Here’s how. read more
The cannabis industry faces challenges in maintaining consistent quality and protecting intellectual property while meeting cost efficiency. read more
Tariffs are inflationary IMF’s Gita Gopinath warns policymakers against potential harm to growth and prices. Markets closely watch U.S. elections. read more